The global frontotemporal dementia therapeutics market is experiencing significant development. This trend can be explained to a rising prevalence of frontotemporal dementia, coupled with advancements in research and manufacture of novel treatments. The market is driven by a mixture of factors, including an elderly population, increasing healthcare